EN
HI
Summary
As of 18 Oct, 2026, Aarti Pharmalabs stock price is ₹873.65. During the trading session, the stock has moved between an intraday low of ₹864.85 and an intraday high of ₹890.65. Over the last 52 weeks, Aarti Pharmalabs has traded between ₹585.00 and ₹1002.40.
The stock has recorded a trading volume of 3,07,606 shares,. Its Average Traded Price (ATP) is ₹877.24, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹873.65.
Aarti Pharmalabs has an upper circuit limit of ₹1048.35 and a lower circuit limit of ₹698.95. The total value traded stands at ₹26.98 CR, and the delivery percentage for the day is 52.81%.
The stock is currently traded with a market lot size of 1. Aarti Pharmalabs also offers a dividend yield of 0.4%.
Aarti Pharmalabs Share Price Chart
Aarti Pharmalabs Share Key Metrics
Volume
3.08 L
Market Cap
7922.24 CR
LTQ@LTP
5@873.65
ATP
877.24
Var Margin
22.59 %
Circuit Range
698.95-1048.35
Delivery %
52.81 %
Value
26.98 CR
ASM/GSM
No
Market Lot
1
Aarti Pharmalabs Fundamentals
P/E Ratio
37.23
P/B Ratio
3.62
Div. Yield
0.4
Sector P/E
40.5
Sector P/B
3.42
Sec. Div. Yield
0.52
Aarti Pharmalabs Resistance and Support
Pivot 863.93
Resistance
First Resistance
869.86
Second Resistance
875.93
Third Resistance
881.86
Support
First Support
857.86
Second Support
851.93
Third Support
845.86
Aarti Pharmalabs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 16 2026 | 867.5 | 873.65 | 1.14% | 890.65 | 864.85 |
| Thu Oct 15 2026 | 865 | 863.79 | -0.44% | 870 | 858 |
| Wed Oct 14 2026 | 884 | 867.65 | -1.91% | 884 | 846.79 |
Aarti Pharmalabs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-28 | Quarterly Results |
| 2026-08-07 | Quarterly Results |
| 2026-05-25 | Audited Results & Final Dividend |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results & Interim Dividend |
| 2025-11-09 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-10 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Aarti Pharmalabs News
Aarti Pharmalabs Ltd - 543748 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Aarti Pharma Labs has filed a writ petition before the Gujarat High Court to challenge an August 2026 order by the Superintendent of Stamps, Gujarat. The contested order levied stamp duty and penalties totaling Rs.59.50 crore related to the company's 2022 demerger.
Sep 30 2026 17:38:20
Aarti Pharmalabs Ltd - 543748 - Updates On Change In Directorate
Aarti Pharma Labs' board approved changes in its Directorate. Shri Rashesh C. Gogri is appointed Managing Director, and Smt. Hetal Gogri Gala is re-designated Whole-time Director, effective October 1, 2026.
Sep 23 2026 18:50:57
Read More
Aarti Pharmalabs Management
| Name | Position |
|---|---|
| Jeevan Mondkar | Company Secretary |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Pharmalabs Similar Stocks
Procter & Gamble Health Ltd.
5200.00
51.00 (0.99%)
Symbiotec Pharmalab Ltd.
1279.50
24.60 (1.96%)
Jupiter Life Line Hospitals Ltd.
247.05
7.40 (3.09%)
Suven Life Sciences Ltd.
303.55
3.30 (1.10%)
Thyrocare Technologies Ltd.
485.25
-2.30 (0.47%)
Bliss GVS Pharma Ltd.
652.00
-2.30 (0.35%)
Morepen Laboratories Ltd.
123.87
-1.73 (1.38%)
Sanofi India Ltd.
2942.10
-15.10 (0.51%)
Aarti Pharmalabs FAQs
The Buying Price of Aarti Pharmalabs share is 873.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Pharmalabs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Pharmalabs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Pharmalabs shares is 37.23. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Pharmalabs shares is 3.62. Useful to assess the stock's value relative to its book value.
To assess Aarti Pharmalabs’s valuation compare Sector P/E, P/B which are 40.5 & 3.42 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Pharmalabs is 7922.24 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Pharmalabs share price is 1002.40 & 585.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Pharmalabs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AARTIPHARM
Or Download Choice FinX App
Invest in AARTIPHARM
